Addex Therapeutics Ltd.
About Addex Therapeutics Ltd.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $7.4M
- Market cap
- $7.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 29, 2020
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Addex Therapeutics Ltd..